Last $6.00 USD
Change Today -0.22 / -3.54%
Volume 33.5K
ATNM On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 5:15 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geraldine A. Henwood Ph.D.

Chief Development Officer of Iomab-B, Actinium Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 3 different organizations across 7 different industries.

See Board Relationships
62$125,000

Background*

Dr. Geraldine A. Henwood, also known as Gerri, Ph.D. has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. Dr. Henwood has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. Dr. Henwood has been the Chief Executive Officer and President of RECRO Pharma, Inc. since 2008. She is a Venture Partner at SCP Vitalife. She is the Founder/President of Malvern Consulting Group. Dr. Henwood has ...

Read Full Background

Corporate Headquarters*

546 Fifth Avenue
New York, New York 10036

United States

Phone: 646-840-5442
Fax: --

Board Members Memberships*

Director
1992-N/A
Former Chief Executive Officer, President and Executive Director
1999-N/A
Founder
2004-2013
Former Director and Chairman of Compensation Committee
2008-Present
Chief Executive Officer and Director
2008-Present
Chief Executive Officer, President and Director
2011-Present
Director and Member of Compensation Committee

Education*

BS
Neumann University

Other Affiliations*

Annual Compensation*

Salary$125,000
Total Annual Compensation$125,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$125,000
Total Short Term Compensation$125,000
Total Calculated Compensation$125,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATNM:US $6.00 USD -0.22

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTINIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.